GANGLIONEUROBLASTOMA
Clinical trials for GANGLIONEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROBLASTOMA trials appear
Sign up with your email to follow new studies for GANGLIONEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo therapy for tough childhood cancer
Disease control OngoingThis study tested whether adding two immunotherapy drugs (dinutuximab and GM-CSF) to standard chemotherapy is safe and feasible for children newly diagnosed with high-risk neuroblastoma, a rare and aggressive nerve cell cancer. About 42 children participated. The goal was to see …
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
Engineered immune cells take aim at childhood cancer
Disease control OngoingThis early-stage study tests whether a patient's own immune cells, modified in a lab to recognize and attack neuroblastoma cells, are safe and tolerable. Up to 65 children and young adults with recurrent or treatment-resistant neuroblastoma will receive these engineered T-cells. …
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
Smarter treatment for childhood cancer: Biology-Guided therapy may reduce side effects
Disease control OngoingThis study tests whether using the tumor's biology and how it responds to treatment can guide therapy for children with non-high-risk neuroblastoma. Some children may only need monitoring instead of immediate treatment, which could avoid unnecessary side effects. The trial enroll…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New scan may outshine standard test for Kids' rare tumors
Diagnosis OngoingThis study tests whether a special PET/CT scan using a radioactive tracer called 68Ga-DOTATATE can better detect neuroendocrine tumors (like neuroblastoma) in children and young adults up to age 30. The scan is compared to the standard MIBG scan to see which one more clearly show…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 12, 2026 13:40 UTC
-
10,000 Kids' tumors analyzed to unlock neuroblastoma secrets
Knowledge-focused OngoingThis research study looks at tumor tissue from children newly diagnosed with neuroblastoma or related tumors. By studying these samples, doctors hope to find biological markers that can predict how the disease will behave and help guide treatment decisions. The study does not tes…
Matched conditions: GANGLIONEUROBLASTOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 26, 2026 04:53 UTC